The Fight Fentanyl Act amends the Office of National Drug Control Policy Authorization Act of 1998 to add new reporting duties for High Intensity Drug Trafficking Areas (HIDTAs), expand permitted HIDTA uses related to fentanyl interdiction, authorize multi‑year funding levels, and require the Attorney General to make additional prosecutorial resources available. The bill specifies the content of HIDTA reports, raises funding levels in several subsections, and creates a mechanism for temporarily reassigning Assistant U.S. Attorneys (AUSAs) to prioritize fentanyl trafficking prosecutions.
For practitioners, the bill shifts programmatic emphasis toward data-driven interdiction and prosecution. Compliance officers and HIDTA managers will face new data‑collection and reporting obligations; U.S. Attorney offices must plan for temporary reassignment requests; and appropriations and budgeting teams should note the new authorized funding streams and their potential pressure on discretionary budgets.
At a Glance
What It Does
Adds an annual HIDTA report focused on fentanyl investigations and seizures, directs HIDTAs to assess capacity shortfalls and recommend fixes, increases authorized HIDTA funding for 2025–2030, broadens permissible HIDTA activities to explicitly include interdiction assistance, and requires DOJ to provide temporary reassignment of AUSAs to prioritize fentanyl cases with a process established within 180 days of enactment.
Who It Affects
Regional HIDTA programs and the Office of National Drug Control Policy (ONDCP) must compile and submit new datasets; U.S. Attorney offices and the Department of Justice must implement temporary reassignments; state, local, and Tribal law enforcement are explicit assistance recipients; Congress and oversight bodies gain new reporting to inform policy and budget decisions.
Why It Matters
The bill channels both money and personnel toward fentanyl interdiction and prosecution, creating a formalized pathway for federal prosecutors to be redirected to fentanyl work and for HIDTAs to supply seizure and predictive data to policymakers — a material change in how federal anti‑fentanyl efforts are resourced and measured.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Act inserts targeted reporting requirements into the HIDTA statute. ONDCP must now publish a yearly account of how HIDTA funds were used in investigations of fentanyl and related substances; that account must include amounts seized and regional HIDTA threat‑assessment data that show trafficking, transportation, and substance‑use patterns.
Separate language requires HIDTAs to identify where they lack capacity to meet their goals and to propose remedies, so the reports are meant to be both descriptive and prescriptive.
On money, the bill adds a new authorization line calling for $333 million per year for fiscal years 2025 through 2030 to support HIDTA activities tied to the statute. It also raises an existing program amount from $10,000,000 to $14,224,000 and explicitly lists interdiction assistance to Federal, State, local, and Tribal law enforcement among permissible uses, while leaving room for ONDCP to designate additional appropriate fentanyl prevention and seizure purposes.The Justice Department must produce personnel capacity for this enforcement push.
The Attorney General is directed to make investigative and prosecutorial resources—specifically through temporary AUS A reassignments—available as practicable for the period covering FY2024 through FY2030. The bill requires the AG to set up, within 180 days, a process by which the ONDCP Director, working with HIDTA executive boards, can request temporary reassignment of an AUSA; those reassignments may be extended long enough to finish active matters.
Practically, that creates a formal request channel from HIDTAs into DOJ for short‑term prosecutorial support.Taken together, the measures push HIDTAs toward standardized fentanyl seizure and predictive data reporting, increase authorized funding for fentanyl‑focused activity, and create a staffing mechanism to move federal prosecutors to high‑priority fentanyl cases upon request.
The Five Things You Need to Know
Section 706(g)(3)(E) requires an annual HIDTA report listing amounts of fentanyl and fentanyl‑related substances seized and including law‑enforcement and predictive data from regional threat assessments.
Section 707(l)(2)(H) forces HIDTAs to report limits on their ability to meet their goals and provide recommendations to fix those limits.
Section 707(p) adds an explicit authorization of $333,000,000 for each fiscal year 2025 through 2030 to support HIDTA‑related activities.
Section 707(s) increases a program figure from $10,000,000 to $14,224,000 and specifically authorizes HIDTA assistance for interdiction of fentanyl and other substances, plus other Director‑designated fentanyl activities.
A new Section 707(t) directs the Attorney General to make investigative and prosecutorial resources available—authorizing temporary reassignment of AUSAs to prioritize fentanyl prosecutions for FY2024–2030—and requires DOJ to create a request process within 180 days for ONDCP and HIDTA executive boards.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Annual HIDTA fentanyl reporting requirement
This addition requires ONDCP to publish a dedicated report describing how HIDTA funds were used to investigate fentanyl and fentanyl‑related trafficking during the prior calendar year. The report must quantify seized fentanyl amounts and surface law‑enforcement and predictive data from regional threat assessments to identify trafficking, transportation, and local substance‑use trends. For HIDTA managers and grant monitors, the provision creates a standardized deliverable that will drive what seizure and analytics data are collected, retained, and shared.
Assessment of HIDTA capacity limits and recommendations
The statute now requires each HIDTA area to identify any limitations that impede the area’s ability to meet statutory purposes and to propose remedies — including reallocating resources, forming partnerships, or seeking statutory or authority changes. That language transforms threat assessments into potential action plans and gives ONDCP and Congress a clearer basis to re‑target funding or recommend legal changes to improve regional performance.
New multi‑year funding authorization
This paragraph inserts a $333 million annual authorization for fiscal years 2025 through 2030. While the bill authorizes specific sums, authorization does not automatically appropriate funds; Congress will still need to provide appropriations. Nonetheless, the explicit multi‑year authorization signals a sustained federal funding commitment and creates a clear figure for budgeting and program planning at ONDCP and HIDTA levels.
Expanded permitted uses and raised program amount
The amendment increases a prior $10 million figure in the statute to $14,224,000 and broadens the list of permissible activities to include assistance to Federal, State, local, and Tribal law enforcement for interdiction of fentanyl and other substances, plus any additional fentanyl‑related purposes the ONDCP Director designates. That gives HIDTAs clearer statutory authority to fund interdiction operations and to absorb new, Director‑approved initiatives without being constrained by an overly narrow purpose statement.
Temporary AUSA reassignment and request process
This new subsection requires the Attorney General to make investigative and prosecutorial personnel available, including through temporary reassignment of AUSAs under existing reassignment authority, for FY2024–2030. It mandates a formal process be established within 180 days by which the ONDCP Director, after consulting HIDTA executive boards, can request a temporarily reassigned AUSA. The provision permits extensions to finish active matters, but it leaves many operational details—priority ranking of requests, duration norms, and inter‑office coordination—to DOJ implementation.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Regional HIDTA programs — receive clearer statutory authority to fund interdiction, new reporting templates, and access to an explicit authorization figure that supports multi‑year planning.
- Office of National Drug Control Policy — gains standardized, fentanyl‑focused data and prescriptive assessments to inform national strategy and to make targeted funding recommendations.
- Federal, State, local, and Tribal law enforcement — become explicit recipients of HIDTA‑funded interdiction assistance and may secure added operational support for fentanyl investigations.
- Department of Justice prosecutors and task forces — obtain formally authorized pathways to request and receive additional AUSA resources to prioritize fentanyl prosecutions.
- Congress and oversight committees — obtain new, data‑rich annual reporting and capacity assessments to guide oversight, policy adjustments, and appropriation decisions.
Who Bears the Cost
- Department of Justice and U.S. Attorney offices — must accommodate temporary reassignments of AUSAs, which can strain local caseload management and require internal reallocation of personnel and supervisory resources.
- Federal budget / appropriations — an authorization of $333 million per year plus increased program figures creates pressure in discretionary spending debates and may crowd other priorities if appropriators allocate matching funds.
- HIDTA and partner agencies — must standardize seizure and predictive‑analysis data collection, which requires staff time, analytical capacity, and possible system upgrades to meet reporting requirements.
- State, local, and Tribal agencies — while eligible for assistance, they may face coordination costs and shifting priorities when federal prosecutorial attention concentrates on fentanyl over other local crime or public‑health initiatives.
Key Issues
The Core Tension
The bill pits a concentrated, enforcement‑first response — moving money and prosecutors to interrupt fentanyl supply chains — against the risk of diverting scarce federal prosecutors, program dollars, and local priorities away from other crimes and public‑health approaches; the statute strengthens interdiction but leaves unanswered how to balance enforcement gains against opportunity costs and data‑quality limits.
The bill's explicit focus on interdiction and prosecution sharpens enforcement tools but also creates trade‑offs that implementation will have to manage. First, the temporary AUSA reassignment mechanism assumes DOJ has fungible prosecutorial capacity; in reality, reassignments will create gaps in other districts or require hiring temporary staff, and the statute does not set prioritization criteria or limits on how many AUSAs a HIDTA request can trigger.
That creates potential interdistrict tension and operational friction within U.S. Attorney offices.
Second, the reporting requirements assume regional HIDTA threat assessments are comparable and rely on consistent definitions and data standards. The statute lists “fentanyl‑related substances” and “predictive data” without defining them, raising questions about measurement consistency: differing lab reporting practices, mixture weights versus counts, and whether seized precursor chemicals are captured.
The expansion of permitted uses — especially the catchall allowing the Director to designate “any additional purpose” for fentanyl activities — creates broad delegation that could enable mission creep away from core HIDTA duties unless ONDCP issues narrow implementing guidance. Finally, the authorization of funding is not equivalent to appropriations; Congress must still fund the authorized sums, and appropriators may modify amounts or direct offsets.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.